1. Home
  2. BPMC vs COLB Comparison

BPMC vs COLB Comparison

Compare BPMC & COLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BPMC
  • COLB
  • Stock Information
  • Founded
  • BPMC 2008
  • COLB 1993
  • Country
  • BPMC United States
  • COLB United States
  • Employees
  • BPMC N/A
  • COLB N/A
  • Industry
  • BPMC Biotechnology: Pharmaceutical Preparations
  • COLB Major Banks
  • Sector
  • BPMC Health Care
  • COLB Finance
  • Exchange
  • BPMC Nasdaq
  • COLB Nasdaq
  • Market Cap
  • BPMC 5.8B
  • COLB 5.2B
  • IPO Year
  • BPMC 2015
  • COLB N/A
  • Fundamental
  • Price
  • BPMC $97.17
  • COLB $24.05
  • Analyst Decision
  • BPMC Buy
  • COLB Hold
  • Analyst Count
  • BPMC 21
  • COLB 15
  • Target Price
  • BPMC $124.05
  • COLB $29.87
  • AVG Volume (30 Days)
  • BPMC 973.2K
  • COLB 2.2M
  • Earning Date
  • BPMC 05-01-2025
  • COLB 04-23-2025
  • Dividend Yield
  • BPMC N/A
  • COLB 5.99%
  • EPS Growth
  • BPMC N/A
  • COLB 1.90
  • EPS
  • BPMC N/A
  • COLB 2.37
  • Revenue
  • BPMC $562,121,000.00
  • COLB $1,830,830,000.00
  • Revenue This Year
  • BPMC $44.85
  • COLB $10.89
  • Revenue Next Year
  • BPMC $32.06
  • COLB $3.66
  • P/E Ratio
  • BPMC N/A
  • COLB $10.14
  • Revenue Growth
  • BPMC 99.19
  • COLB N/A
  • 52 Week Low
  • BPMC $73.04
  • COLB $18.11
  • 52 Week High
  • BPMC $121.90
  • COLB $32.85
  • Technical
  • Relative Strength Index (RSI)
  • BPMC 59.54
  • COLB 57.53
  • Support Level
  • BPMC $87.03
  • COLB $23.16
  • Resistance Level
  • BPMC $104.86
  • COLB $24.02
  • Average True Range (ATR)
  • BPMC 3.86
  • COLB 0.74
  • MACD
  • BPMC 1.24
  • COLB 0.25
  • Stochastic Oscillator
  • BPMC 64.38
  • COLB 92.91

About BPMC Blueprint Medicines Corporation

Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.

About COLB Columbia Banking System Inc.

Columbia Banking System Inc is a registered bank holding company whose wholly-owned banking subsidiary is Columbia State Bank. The company provides a full range of banking services to small and medium sized businesses, professionals, and individuals throughout Washington, Oregon, Idaho, and California. The company's subsidiary Columbia Trust Company is an Oregon trust company that provides agency, fiduciary, and other related trust services with offices in Washington, Oregon, and Idaho. The firm offers various products and services under Personal Banking, Business Banking, and Wealth Management divisions.

Share on Social Networks: